Orbis Medicines ApS is a Danish APS based in Frederiksberg, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2021, the company has 31 employees and reported revenue of -114,1 mio. kr. in its latest annual filing.
Selskabet tegnes af en direktør i forening med formanden for bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er forskning, udvikling og kommercialisering af medicinske produkter samt aktiviteter, der efter bestyrelsens skøn er forbundet dermed.
In its most recent annual report (2025), Orbis Medicines ApS reported a gross profit of -114,1 mio. kr.. The figures on this page draw on 4 annual filings covering 2022 to 2025. The bottom line showed a net loss of 136,5 mio. kr..
